Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis
Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer often diagnosed at an advanced stage, leading to a poor prognosis. The tumor microenvironment (TME) plays a crucial role in driving metastasis, with inflammatory signaling pathways contributing to tumor progression and th...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07810-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849341645485506560 |
|---|---|
| author | Joana E. Aggrey-Fynn Meghana Manjunath Ashish Rajput Amro M. Abdelrahman Julia Thiel Mark J. Truty Andrew Clark Meng Dong Steven A. Johnsen |
| author_facet | Joana E. Aggrey-Fynn Meghana Manjunath Ashish Rajput Amro M. Abdelrahman Julia Thiel Mark J. Truty Andrew Clark Meng Dong Steven A. Johnsen |
| author_sort | Joana E. Aggrey-Fynn |
| collection | DOAJ |
| description | Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer often diagnosed at an advanced stage, leading to a poor prognosis. The tumor microenvironment (TME) plays a crucial role in driving metastasis, with inflammatory signaling pathways contributing to tumor progression and therapy resistance. However, the combined effects of inflammatory and oncogenic signaling on the epigenetic regulation of PDAC metastasis are poorly understood. Here, we demonstrate that tumor necrosis factor-alpha (TNFα) and epidermal growth factor (EGF) signaling converge to regulate PDAC cell migration through the activation of NF-κB and AP-1 transcription factors. Using single-cell RNA sequencing, in vitro and in vivo models, we show that the simultaneous activation of these pathways with TNFα and EGF cooperatively induces the expression of genes associated with cell motility and migration. Consistently, combinatorial induced genes are co-regulated by the transcription factors FOSL1 and RELA. Remarkably, inhibition of NF-κB transcriptional activity with a glucocorticoid receptor (GR) mixed agonist significantly reduced PDAC cell migration by decreasing RNA polymerase II recruitment to target genes. These findings reveal a novel mechanism by which inflammatory and oncogenic pathways cooperate to drive PDAC metastasis and highlight the therapeutic potential of GR agonists in mitigating tumor cell migration. Our study offers promising avenues for developing mechanism-based therapeutic strategies in PDAC management. |
| format | Article |
| id | doaj-art-72c3e81f2421498e82e6dfb7be2e3cfa |
| institution | Kabale University |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-72c3e81f2421498e82e6dfb7be2e3cfa2025-08-20T03:43:34ZengNature Publishing GroupCell Death and Disease2041-48892025-07-0116111210.1038/s41419-025-07810-xTherapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasisJoana E. Aggrey-Fynn0Meghana Manjunath1Ashish Rajput2Amro M. Abdelrahman3Julia Thiel4Mark J. Truty5Andrew Clark6Meng Dong7Steven A. Johnsen8Robert Bosch Center for Tumor Diseases (RBCT)Robert Bosch Center for Tumor Diseases (RBCT)Robert Bosch Center for Tumor Diseases (RBCT)Department of Surgery, Mayo ClinicDr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of TübingenDepartment of Surgery, Mayo ClinicInstitute of Cell Biology and Immunology, University of StuttgartDr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of TübingenRobert Bosch Center for Tumor Diseases (RBCT)Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer often diagnosed at an advanced stage, leading to a poor prognosis. The tumor microenvironment (TME) plays a crucial role in driving metastasis, with inflammatory signaling pathways contributing to tumor progression and therapy resistance. However, the combined effects of inflammatory and oncogenic signaling on the epigenetic regulation of PDAC metastasis are poorly understood. Here, we demonstrate that tumor necrosis factor-alpha (TNFα) and epidermal growth factor (EGF) signaling converge to regulate PDAC cell migration through the activation of NF-κB and AP-1 transcription factors. Using single-cell RNA sequencing, in vitro and in vivo models, we show that the simultaneous activation of these pathways with TNFα and EGF cooperatively induces the expression of genes associated with cell motility and migration. Consistently, combinatorial induced genes are co-regulated by the transcription factors FOSL1 and RELA. Remarkably, inhibition of NF-κB transcriptional activity with a glucocorticoid receptor (GR) mixed agonist significantly reduced PDAC cell migration by decreasing RNA polymerase II recruitment to target genes. These findings reveal a novel mechanism by which inflammatory and oncogenic pathways cooperate to drive PDAC metastasis and highlight the therapeutic potential of GR agonists in mitigating tumor cell migration. Our study offers promising avenues for developing mechanism-based therapeutic strategies in PDAC management.https://doi.org/10.1038/s41419-025-07810-x |
| spellingShingle | Joana E. Aggrey-Fynn Meghana Manjunath Ashish Rajput Amro M. Abdelrahman Julia Thiel Mark J. Truty Andrew Clark Meng Dong Steven A. Johnsen Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis Cell Death and Disease |
| title | Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis |
| title_full | Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis |
| title_fullStr | Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis |
| title_full_unstemmed | Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis |
| title_short | Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis |
| title_sort | therapeutic targeting of fosl1 and rela dependent transcriptional mechanisms to suppress pancreatic cancer metastasis |
| url | https://doi.org/10.1038/s41419-025-07810-x |
| work_keys_str_mv | AT joanaeaggreyfynn therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT meghanamanjunath therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT ashishrajput therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT amromabdelrahman therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT juliathiel therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT markjtruty therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT andrewclark therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT mengdong therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis AT stevenajohnsen therapeutictargetingoffosl1andreladependenttranscriptionalmechanismstosuppresspancreaticcancermetastasis |